Evidence map›Paper›PMID 27603413›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2016

GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.

Shaihla A Khan, Brian S Edwards, Aaron Muth, Paul R Thompson, Brian D Cherrington, Amy M Navratil

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. GnRH Induces Citrullination of the Cytoskeleton in Murine Gonadotrope Cells.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Review
  7. The virtues and vices of protein citrullination.Royal Society open science · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shaihla A KhanDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Brian S EdwardsDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Aaron MuthDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Paul R ThompsonDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Brian D CherringtonDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Amy M NavratilDepartment of Zoology and Physiology (S.A.K., B.S.E., B.D.C., A.M.N.), University of Wyoming, Laramie, Wyoming 82071; and Department of Biochemistry and Molecular Pharmacology (A.M., P.R.T.), University of Massachusetts Medical School, Worcester, Massachusetts 01605.
University of Wyoming · USUniversity of Massachusetts Chan Medical School · US

Funding

Wyoming INBRE Phase 4- Equipment Supplement for x-ray diffractometer for Center for Advanced Scientific InstrumentationP20GM103432 · NIGMS · UNIVERSITY OF WYOMING · PI Robert Scott Seville · 2012 to 2026
$56.8M
Chemical probes to decipher PAD biologyR35GM118112 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Paul R Thompson · 2016 to 2026
$9.5M
Haloacetamidine based inactivators of Protein Arginine Deiminase 4R01GM079357 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2007 to 2016
$3.3M
Identification of Citrullinated Biomarkers of Inflammatory Disease and CancerR01GM110394 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2014 to 2016
$1.7M
NIGMS NIH HHS P20 GM103432NIGMS NIH HHS R01 GM079357NIGMS NIH HHS R01 GM110394NIGMS NIH HHS R35 GM118112
6 · The paper itself

Abstract

Peptidylarginine deiminase (PAD) enzymes convert histone tail arginine residues to citrulline resulting in chromatin decondensation. Our previous work found that PAD isoforms are expressed in female reproductive tissues in an estrous cycle-dependent fashion, but their role in the anterior pituitary gland is unknown. Thus, we investigated PAD expression and function in gonadotrope cells. The gonadotrope-derived LβT2 cell line strongly expresses PAD2 at the protein level compared with other PAD isoforms. Consistent with this, PAD2 protein expression is highest during the estrous phase of the estrous cycle and colocalizes with the LH β-subunit in the mouse pituitary. Using the GnRH agonist buserelin (GnRHa), studies in LβT2 and mouse primary gonadotrope cells revealed that 30 minutes of stimulation caused distinct puncta of PAD2 to localize in the nucleus. Once in the nucleus, GnRHa stimulated PAD2 citrullinates histone H3 tail arginine residues at sites 2, 8, and 17 within 30 minutes; however, this effect and PAD2 nuclear localization was blunted by incubation of the cells with the pan-PAD inhibitor, biphenyl-benzimidazole-Cl-amidine. Given that PAD2 citrullinates histones in gonadotropes, we next analyzed the functional consequence of PAD2 inhibition on gene expression. Our results show that GnRHa stimulates an increase in LHβ and FSHβ mRNA and that this response is significantly reduced in the presence of the PAD inhibitor biphenyl-benzimidazole-Cl-amidine. Overall, our data suggest that GnRHa stimulates PAD2-catalyzed histone citrullination in gonadotropes to epigenetically regulate gonadotropin gene expression.

Indexed as

AnimalsCatalysisCell LineCell NucleusChromatinCitrullinationCitrullineEstrous CycleFemaleGene ExpressionGonadotrophsGonadotropin-Releasing HormoneHistonesLuteinizing Hormone, beta SubunitMicePituitary Gland, AnteriorChromatinCitrullineGonadotropin-Releasing HormoneHistonesLuteinizing Hormone, beta SubunitProtein-Arginine DeiminasesRNA, Messenger

Identifiers

PMID27603413
PMCPMC5045497
OpenAlexW2513432579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.